Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Blue Jet Healthcare is a specialty pharmaceutical ingredients maker focused on niche categories: contrast media intermediates (for X-ray/CT/MRI dyes, supplied to large global contrast media makers), high-intensity sweeteners (saccharin and derivatives), and pharma intermediates/APIs including CDMO-style contracts. Long-standing relationships with a concentrated set of European customers, and new capacity for contrast intermediates, drive growth.
One of the few large-scale global suppliers of contrast media intermediates.
Blue Jet Healthcare Ltd. is a constituent of NIFTY 500, NIFTY SMALLCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Blue Jet Healthcare Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY25 (year ended 31 Mar 2025).
| Metric | FY25 | FY24 |
|---|---|---|
| Free cash flow | ₹-34 Cr | ₹68 Cr |
| Current ratio | 3.93 | 3.43 |
Open the full income statement, balance sheet and cash flow for BLUEJET →
As disclosed for the quarter ended 9 Jul 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.